The interactions of rifampicin and macrophage membrane models were evaluated.
Several biophysical techniques were executed to assess drug-membrane interaction.
The results confirm that the interactions of RIF with membranes are more pronounced under in vitro pathological conditions.
This work could lead to the development of new anti-TB drugs with higher efficacy and fewer toxic effects.